Ravi K Gupta

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
    Daniel Sauter
    Institute of Molecular Virology, Ulm University Medical Center, 89069, Ulm, Germany
    Retrovirology 8:103. 2011
  2. ncbi Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine
    Ravindra K Gupta
    Division of Infection and Immunity, University College London Medical School, London, United Kingdom
    Pediatr Infect Dis J 29:e57-62. 2010
  3. ncbi The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains
    Jean L Mbisa
    Virus Reference Department, Microbiology Services, Colindale, Health Protection Agency, London, UK
    Retrovirology 8:31. 2011

Collaborators

  • Diana M Gibb
  • Deenan Pillay
  • A Sarah Walker
  • Jean L Mbisa
  • Daniel Sauter
  • Chris M Parry
  • Sarah A Walker
  • Veronica Mulenga
  • Frank Kirchhoff
  • Stephane Hue
  • Sarah J Petit
  • Greg J Towers
  • Moxmalama Kalumbi
  • Chifumbe Chintu
  • Patricia A Cane
  • Jean Christophe Plantier
  • Desire Kabamba

Detail Information

Publications3

  1. ncbi HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
    Daniel Sauter
    Institute of Molecular Virology, Ulm University Medical Center, 89069, Ulm, Germany
    Retrovirology 8:103. 2011
    ..Here, we examined how long Group P may have been circulating in humans and determined its capability to antagonize human tetherin as an indicator of adaptation to humans...
  2. ncbi Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine
    Ravindra K Gupta
    Division of Infection and Immunity, University College London Medical School, London, United Kingdom
    Pediatr Infect Dis J 29:e57-62. 2010
    ..There are few medium-term virologic data in children from resource-limited settings taking adult fixed-dose-combination antiretroviral therapy (cART) without viral load monitoring...
  3. ncbi The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains
    Jean L Mbisa
    Virus Reference Department, Microbiology Services, Colindale, Health Protection Agency, London, UK
    Retrovirology 8:31. 2011
    ..In this study we examined the genotypic, phenotypic and fitness correlates associated with the development of Q151M MDR in the absence of viral load monitoring...